Evidence map›Paper›PMID 25161232›Full record

ArticleBioinformatics (Oxford, England)2014

Experimental design schemes for learning Boolean network models.

Nir Atias, Michal Gershenzon, Katia Labazin, Roded Sharan

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Designing Experiments to Discriminate Families of Logic Models.Frontiers in bioengineering and biotechnology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nir AtiasBlavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.
Michal GershenzonBlavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.
Katia LabazinBlavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.
Roded SharanBlavatnik School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationA holy grail of biological research is a working model of the cell. Current modeling frameworks, especially in the protein-protein interaction domain, are mostly topological in nature, calling for stronger and more expressive network models. One promising alternative is logic-based or Boolean network modeling, which was successfully applied to model signaling regulatory circuits in human. Learning such models requires observing the system under a sufficient number of different conditions. To date, the amount of measured data is the main bottleneck in learning informative Boolean models, underscoring the need for efficient experimental design strategies.

resultsWe developed novel design approaches that greedily select an experiment to be performed so as to maximize the difference or the entropy in the results it induces with respect to current best-fit models. Unique to our maximum difference approach is the ability to account for all (possibly exponential number of) Boolean models displaying high fit to the available data. We applied both approaches to simulated and real data from the EFGR and IL1 signaling systems in human. We demonstrate the utility of the developed strategies in substantially improving on a random selection approach. Our design schemes highlight the redundancy in these datasets, leading up to 11-fold savings in the number of experiments to be performed. AVAILABILITY AND IMPLEMENTATION: Source code will be made available upon acceptance of the manuscript.

Indexed as

Models, BiologicalSignal TransductionAlgorithmsErbB ReceptorsHumansInterleukin-1Research DesignErbB ReceptorsInterleukin-1

Identifiers

PMID25161232
PMCPMC4147904
OpenAlexW2112407533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.